12 Stimulates c-Jun NH2-terminal Kinase through the Small G Proteins Ras and Rac*

  1. Lila R. Collins,
  2. Audrey Minden§,
  3. Michael Karin and
  4. Joan Heller Brown
  1. From the Department of Pharmacology, University of California at San Diego, La Jolla, California 92093-0636
  1. To whom correspondence should be addressed:
    Dept. of Pharmacology 9500 Gilman Dr., La Jolla, CA 92093-0636.

Abstract

The pertussis toxin (PTX) insensitive heterotrimeric G protein G12 has been implicated in mitogenesis and transformation, but its direct effectors remain unknown. To define potential signaling pathways utilized by G12, we expressed an activated mutant of its α subunit, Gα12(Q229L), in HEK293 cells and examined its effects on Ras and mitogen-activated protein kinases (MAPKs). Transient expression of activated Gα12 increased the percentage of Ras in the active, GTP-bound state, stimulated c-Jun NH2-terminal kinase (JNK) activity, and enhanced the transcriptional activity of c-Jun. Dominant negative Ras (N17Ras) inhibited Gα12-mediated JNK activation in NIH3T3 cells but failed to do so in HEK293 cells. In contrast, dominant negative Rac (N17Rac1) inhibited JNK activation by Gα12 in HEK293 cells as well as three other cell lines. In 1321N1 cells, where thrombin stimulates G12-dependent mitogenesis, coexpression of N17Rac1 or a dominant negative mutant of MEKK1 (MEKKΔ(K432M)) inhibits c-Jun/AP-1 sensitive reporter gene expression stimulated by thrombin or Gα12. These data demonstrate that the α subunit of the heterotrimeric G protein G12, like tyrosine kinase growth factor receptors, activates Ras and recruits a signal transduction pathway involving the small GTP-binding protein Rac that leads to JNK activation.

Footnotes

  • Supported by National Institutes of Health Predoctoral Fellowship GM17277. Work was in partial fulfillment of the Ph.D. degree in the Biomedical Sciences Graduate Program.

  • § Supported by National Institutes of Health Postdoctoral Fellowship F32CA65105.

  • * This work was supported in part by National Institutes of Health Grants GM36927 (to J. H. B.) and HL35018 (to M. K.). The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

  • 1 The abbreviations used are:

    JNK

    c-Jun NH2-terminal kinase

    MAPK

    mitogen-activated protein kinase

    ERK

    extracellular signal-regulated kinase

    mAChR

    muscarinic acetylcholine receptor

    PTX

    pertussis toxin

    PAGE

    polyacrylamide gel electrophoresis

    HA

    hemagglutinin

    GST

    glutathione S-transferase.

    • Received March 27, 1996.
    • Revision received May 3, 1996.
« Previous | Next Article »Table of Contents
  • Advertisement
  • Advertisement
Advertisement